AFP and neoplasm: For patient HB102/106, we observed a rising CTC burden between TARE and hepatectomy procedures when tumor burden was also rising; during this same timeframe, AFP levels for this patient had already reached the maximum measurable level and, therefore, provided no further information about the response.